These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2008-001340-39 Hydroxychloroquine as Steroid-Sparing Agent in pulmonary Sarcoidosis (HySSAS). A multicenter, prospectic, controlled, randomized trial. not-yet-due
Listed as ongoing, but also has a completion date 2011-002749-37 Validation of digital-PCR analysis through programmed imatinib interruption in PCR negative chronic myeloid leukemia patients. 2018-11-28 bad-data
Completed, but no date, and reported results 2014-003126-40 Allogeneic haematopoietic stem cell transplantation from a matched donor in patients with chronic myeloid leukemia failing to gain normal hemopoiesis under TKIs therapy bad-data
Ongoing 2016-003970-41 A PHASE 2 OPEN LABEL STUDY OF ORAL LORLATINIB (PF-06463922) IN PATIENTS WITH RELAPSED ALK POSITIVE LYMPHOMA PREVIOUSLY TREATED WITH ALK INHIBITORS STUDIO DI FASE 2 IN APERTO CON LORLATINIB (PF-0646... not-yet-due
Other 2017-000705-20 International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones not-yet-due
Ongoing 2019-000510-11 A Phase 2, open label, multicenter, single arm trial evaluating the activity and safety of Abemaciclib + Aromatase Inhibitors (AIs) after 1st-line treatment with High-Dose Fulvestrant in Hormone-Recep... not-yet-due